Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6570.0000
14.00
(
0.21
%)
NSE
Oct 14, 2025
14:42 PM
32.59% Gain from 52W Low
Volume:
262.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
08 Aug 2020
6570.00
0.21%
Divi's Labs (REDUCE): Q1 beat due to lumpiness retain REDUCE on full valuations
Sell:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 2850
Target
BOB Capital Markets Ltd.
Strong execution in Q1 drove a sharp 39% EBITDA beat for Divi's Labs (DIVI).
Divi's Laboratories .. has an
average target
of 6414.33 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, Kernex Microsystems receives RDSO approval for Kavach System 4.0
Trendlyne Marketwatch |
14 Oct 2025, 02:43PM
IPO market cools: LG Electronics, Canara Robeco, plus seven listings, and a new issue
|
13 Oct 2025, 04:01PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022